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Abstract
Background: Evidence suggests that adenosine acts via cardiac A1 adenosine receptors (A1ARs) to protect embryos against
hypoxia. During embryogenesis, A1ARs are the dominant regulator of heart rate, and A1AR activation reduces heart rate.
Adenosine action is inhibited by caffeine, which is widely consumed during pregnancy. In this study, we tested the
hypothesis that caffeine influences developing embryos by altering cardiac function.
Methodology/Principal Findings: Effects of caffeine and adenosine receptor-selective antagonists on heart rate were
studied in vitro using whole murine embryos at E9.5 and isolated hearts at E12.5. Embryos were examined in room air (21%
O2) or hypoxic (2% O2) conditions. Hypoxia decreased heart rates of E9.5 embryos by 15.8% and in E12.5 isolated hearts by
27.1%. In room air, caffeine (200 mM) had no effect on E9.5 heart rates; however, caffeine increased heart rates at E12.5 by
37.7%. Caffeine abolished hypoxia-mediated bradycardia at E9.5 and blunted hypoxia-mediated bradycardia at E12.5. Real-
time PCR analysis of RNA from isolated E9.5 and E12.5 hearts showed that A1AR and A2aAR genes were expressed at both
ages. Treatment with adenosine receptor-selective antagonists revealed that SCH-58261 (A2aAR-specific antagonist) had no
affects on heart function, whereas DPCPX (A1AR-specific antagonist) had effects similar to caffeine treatment at E9.5 and
E12.5. At E12.5, embryonic hearts lacking A1AR expression (A1AR2/2) had elevated heart rates compared to A1AR+/2
littermates, A1AR2/2 heart rates failed to decrease to levels comparable to those of controls. Caffeine did not significantly
affect heart rates of A1AR2/2 embryos.
Conclusions/Significance: These data show that caffeine alters embryonic cardiac function and disrupts the normal cardiac
response to hypoxia through blockade of A1AR action. Our results raise concern for caffeine exposure during
embryogenesis, particularly in pregnancies with increased risk of embryonic hypoxia.
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Introduction
Mature and developing mammals modulate cardiac output
through alteration of heart rate and cardiac contractility [1–6]. In
developing embryos, heart rate changes play an important role in
regulating cardiac output [1–3]. Factors that alter heart rate thus
influence cardiac output and tissue perfusion in early development.
In the embryo and fetus, hypoxia is a stressor with multiple
etiologies that include placental insufficiency, maternal smoking,
anemia, umbilical cord compression, pre-eclampsia, and living at
high altitudes [7]. In mammals, embryonic hypoxia [8,9] results in
intrauterine growth restriction and reduced birth weight [10].
Hypoxia is an important part of the normal development process
that drives proper outflow tract formation in the heart, as well as
formation of embryonic vessels [11–13].
Adenosine is a crucial humoral mediator of functional changes
induced by hypoxia [8,9,14]. Importantly, hypoxia also plays a key
role in inflammation by inducing adenosine production [15–17].
Under basal conditions, adenosine levels are low and climb more
than 100-fold in hypoxia, ischemia, and inflammation [18].
Adenosine exerts its effects via G protein-coupled receptors that
include the A1, A2a, A2b, and A3 subtypes [18]. During
embryogenesis, adenosine A1 receptors (A1ARs) are among the
earliest expressed G protein-coupled receptors in the heart, with
expression observed when the myocardial tube first forms [5]. At
the onset of spontaneous cardiac contractions on embryonic day
(E) 8.0 in mice, A1AR activation reduces embryonic heart rate
[19]. This effect on heart rate becomes more pronounced as
gestation progresses [19]. Responsiveness to adrenergic and
muscarinic stimuli develops after responsiveness to adenosine,
identifying the adenosinergic system as the dominant regulator of
early embryonic cardiac function [19].
Recent studies show that adenosine acts via A1ARs in the heart
to protect embryos against hypoxia [9,20]. Embryos lacking
cardiac A1ARs that are exposed to hypoxia have decreased
viability as compared to embryos expressing cardiac A1ARs [20].
The mechanisms by which cardiac A1AR signaling mediates
embryonic protection in hypoxia are not fully known. Our
previous work has shown that with the loss of A1AR there is less
stabilized hypoxia inducible factor 1 (HIF-1) protein in hypoxia
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required for normal heart development and mediates a switch
from oxidative to glycolytic metabolism to protect cells under
hypoxic conditions [13,21].
Caffeine is a multifunctional compound that influences
intracellular calcium levels, inhibits phosphodiesterase activity,
and blocks GABA receptors [22]. Yet, at concentrations associated
with typical consumption, the predominant effect of caffeine is
direct antagonism of adenosine at the receptor level [22]. Caffeine
consumption during the first month of pregnancy is reported by
60% of women, with 16% consuming 150 mg or more per day
[23]. Although caffeine has not been shown to be teratogenic in
humans, consumption during pregnancy is associated with an
increased risk of spontaneous abortions and reduced birth weight
[18,24–30]. In murine models, exposure to a single dose of caffeine
during embryogenesis results in increased body fat and altered
cardiac function in adulthood, indicating that caffeine exposure
during early development can have long-lasting adverse effects
[28].
Considering that adenosine protects the embryo against hypoxia
and that A1ARs are the dominant regulator of embryonic heart
rate, we postulated that caffeine alters the normal embryonic
cardiac response to hypoxia. To test this hypothesis, we examined
responses to hypoxia and adenosine receptor blockade on
embryonic cardiac activity at two ages spanning the critical period
of cardiovascular morphogenesis, E9.5 and E12.5 [31]. We now
report that caffeine influences embryonic heart function and
impairs normal cardiac responses to hypoxia through blockade of
A1ARs.
Results
Effects of Caffeine on Embryonic Heart Rate in Room Air
To assess the effects of caffeine on embryonic heart function,
whole embryos at E9.5 or isolated hearts at E12.5 were studied. At
E9.5, the heart is at an early stage of cardiogenesis, corresponding
to only one and a half days after the start of cardiac contractility
[19,31]. E12.5 represents a later stage of cardiogenesis, and this
stage is known to be sensitive to adenosine signaling [19,31].
Before treatments, baseline heart rates were measured following
a 1–2 h period. Mean baseline heart rates in the C57Bl/6 embryos
were 109.2 beats per minute (BPM) at E9.5 (CI: 106.8–111.6,
n=167) and 124.2 BPM at E12.5 (CI: 120.7–127.6, n=336).
There was a significant age-dependent increase in mean baseline
heart rates (p=0.0001). These values are similar to those observed
for murine embryos studied in culture [19,32], in vivo using
Doppler ultrasonography, or in situ via hysterectomy [33–36].
Baseline heart rates between C57Bl/6 comparison groups were
not significantly different. In control experiments, heart rates were
stable during the time required to conduct these studies.
At E9.5, caffeine treatment in room air had no effect on heart
rates, with 1 mM being the highest concentration tested (Fig. 1A).
In comparison, caffeine caused concentration-dependent increases
in heart rate at E12.5 (Fig. 1B and 1C). Initially, we treated the
same hearts with increasing doses of caffeine over time, which
indicated that heart rates were affected at doses between 100 nM
and 1 mM. Next, we refined this protocol and treated hearts with
a single dose of caffeine between 50 nM and 1 mM, and used
these results to determine the Emax and EC50. In the E12.5 hearts,
caffeine treatment increased heart rates to an Emax of 38% above
baseline levels (400 mM), with an EC50 of 118.4 mM (Fig. 1C).
Interestingly, the magnitude of heart rate elevation decreased at
1 mM relative to the Emax (Fig. 1C).
Effects of Caffeine on the Response to Hypoxia
A1AR action in the heart mediates protective embryonic effects
against hypoxia [20], and A1AR agonists decrease heart rate as
Figure 1. Caffeine concentration-response curves at E9.5 and
E12.5. A and B: Specimens were treated with increasing concentrations
of caffeine (E9.5, n=14; E12.5, n=20) or vehicle (E9.5, n=13; E12.5,
n=17). In room air, caffeine had no effect at E9.5 (A) but caused a
concentration-dependent increase in heart rates at E12.5 (B). C: A
concentration-response curve at E12.5 was produced by treating
individual hearts with one concentration of caffeine or vehicle (n=9–
10 per concentration). At E12.5, the Emax was at 40 mM where caffeine
increased heart rates to 137.7% of baseline and the EC50 was 118.4 mM.
Heart rates were normalized to baseline. Mean 6 SEM are shown.
X-axes are logarithmically scaled. * p,0.05, ** p,0.01, *** p,0.001
caffeine compared to vehicle.
doi:10.1371/journal.pone.0028296.g001
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receptors [22], we examined whether caffeine disrupts embryonic
cardiac responses to hypoxia by exposing cultured tissues to 2%
O2 in the presence of 200 mM caffeine or vehicle. This
concentration of caffeine was selected based on concentration-
response data showing that the compound alters heart function at
this concentration.
To confirm that 2% O2 treatment resulted in tissue hypoxia,
embryos at E9.5 and hearts at E12.5 were cultured in 2% O2 or
room air for 1 h in the presence of Hypoxyprobe-1, which forms
conjugates when tissue O2 levels fall below 10 mm Hg [11].
Analysis of tissue sections showed that 2% O2 induced
Hypoxyprobe-1 labeling (Fig. 2B and 2D) as compared to
normoxic controls (Fig. 2A and 2C).
Experiments were first conducted in room air to determine
whether heart rates were stable over the time required to conduct
these experiments (Fig. 3A and 3B). At both ages, heart rates in
vehicle-treated specimens did not vary over time (Fig. 3A and
3B). At E9.5, 200 mM caffeine treatment in room air had no
e f f e c t so nh e a r tr a t e sa sc o m p a r e d to vehicle (Fig. 3A). At E12.5,
hearts treated with 200 mM caffeine in room air exhibited
sustained elevations in heart rate above vehicle levels over time
(Fig. 3B).
At E9.5 and E12.5, heart rates decreased in hypoxia then
increased following recovery in room air for vehicle-treated
specimens (Fig. 3C and 3D). This observation is consistent with
results from previous studies of E10.5–16.5 murine embryos
studied in situ via hysterectomy [37]. The magnitude of embryo
bradycardia that we observed was greater at E12.5, where heart
rates decreased by 27%, as compared to E9.5, where heart rates
decreased by 16% (Fig. 3C and 3D). At E9.5, the mean vehicle
heart rates returned to baseline after room air recovery, whereas
E12.5 heart rates only partially recovered after returning to room
air (Fig. 3C and 3D).
At E9.5, caffeine treatment abolished the hypoxia-mediated
heart rate reduction (Fig. 3C). At E12.5, caffeine treatment
elevated heart rates, resulting in blunted hypoxia-mediated heart
rate reductions (Fig. 3D). In the presence of caffeine, E12.5 hearts
exposed to hypoxia exhibited delayed heart rate reduction below
baseline with a diminished maximal decrease of 13% compared to
27% for the vehicle-treated hearts.
Adenosine Receptor Gene Expression
We next assessed adenosine receptor gene expression in
embryonic hearts. Quantitative real-time PCR analysis was
performed using RNA isolated from embryonic hearts at E9.5
and at E12.5. Real-time PCR revealed the presence of A1AR and
A2aAR gene expression in E9.5 and E12.5 embryonic hearts
(Fig. 4). In contrast, A2bAR and A3AR gene expression levels were
extremely low at both ages (Fig. 4).
Effects of Selective Adenosine Receptor Antagonists in
Response to Hypoxia
Because caffeine is a non-selective adenosine receptor antago-
nist, we examined the effects of A1AR and A2aAR specific
antagonists on heart rates. At both E9.5 and E12.5, embryonic
heart rates in room air did not change following the addition of
SCH-58261, an A2aAR specific antagonist (Fig. 5A and 5B), with
the highest concentration tested being 10 mM (E12.5 vehicle,
n=17; E12.5 SCH-58261, n=15). Heart rate reductions in
hypoxia were similar between SCH-58261 and vehicle-treated
groups (Fig. 5A and 5B).
In contrast to that seen with an A2AR antagonist, DPCPX
treatment affected embryonic heart function at both ages. In
room air (t=20 min), DPCPX caused significant elevations in
heart rates that were more pronounced at E12.5 (67% increase)
than at E9.5 (10% increase, Fig. 5A and 5B). At both ages, unlike
vehicle-treated groups, heart rates did not decrease below baseline
when exposed to DPCPX in hypoxia (Fig. 5A and 5B). Although
E12.5 heart rates did not fall below baseline in hypoxia in the
presence of DPCPX, they decreased when exposed to hypoxia
(Fig. 5B). In room air, the heart rate elevation observed in the
DPCPX-treated E12.5 hearts diminished over time. This
decrease was not statistically significantly different as compared
to t=20 min levels (Fig. 5C), suggesting that heart rate reductions
in hypoxia are attributed to low O2 levels and not to waning
effects of DPCPX.
Effects of A1AR Loss on Embryonic Response to Caffeine
and Hypoxia
To further characterize the role of A1ARs in the response to
caffeine and hypoxia, embryos from global A1AR knockout mice
were studied. At E9.5, baseline heart rates did not differ by A1AR
genotype (Table 1). In contrast, E12.5 A1AR 2/2 specimens had
significantly higher baseline heart rates compared to A1AR +/+
and A1AR +/2 hearts (Table 1). There were no differences in
baseline heart rates between E12.5 A1AR +/+ and A1AR +/2
hearts (Table 1).
Pharmacological studies indicated that caffeine response profiles
were similar to those of A1AR-specific antagonists. To assess if the
positive chronotropic effects of caffeine at E12.5 are mediated
through blockade of A1ARs, effects of 200 mM caffeine in hearts
lacking A1AR expression were examined. Following caffeine
treatment, heart rates in A1AR 2/2 specimens were not
significantly different from vehicle-treated specimens (Fig. 6).
Figure 2. Exposure to 2% O2 induces embryonic tissue
hypoxia. E9.5 embryos (A and B) and E12.5 hearts (C and D) were
incubated with Hypoxyprobe-1 for 1 h under hypoxic (2% O2; B and D)
or normoxic conditions (A and C). Immunohistochemistry against
Hypoxyprobe-1 conjugates (green), which form at ,10 mm Hg,
demonstrated an increase in tissue hypoxia when embryonic tissues
were exposed to 2% O2 for 1 h. V, ventricle. Scale bar: 200 mM (A and B),
100 mM (C and D).
doi:10.1371/journal.pone.0028296.g002
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significantly compared to vehicle-treated specimens by 22% above
baseline (Fig. 6). These results indicate that effects of caffeine on
E12.5 heart rate in room air are mediated through A1ARs.
To further probe the role of A1ARs on hypoxia-induced
bradycardia, effects of hypoxia were examined in A1AR deficient
embryos. At E9.5, the response to hypoxia was affected by
genotype (Fig. 7A). In hypoxia, heart rates of A1AR +/+ and
A1AR +/2hearts had maximal decreases of 12% and 10%
(Fig. 7A), respectively. Response profiles of A1AR +/+ and +/2
hearts did not differ (p=0.502, data not shown). In contrast, E9.5
A1AR 2/2 embryos exhibited impaired hypoxia-mediated heart
Figure 3. Caffeine effects on embryonic heart function at E9.5 and E12.5 under normoxic and hypoxic (2% O2) conditions. In room
air, E9.5 embryos (A) and E12.5 hearts (B) were treated with 200 mM caffeine (E9.5, n=20; E12.5, n=17) or vehicle (E9.5, n=24; E12.5, n=17) at 15 min,
as indicated by arrows. At both ages, heart rates were stable for the duration of the experiment, as demonstrated by lack of heart rate variability in
vehicle-treated specimens (E9.5, p=0.394; E12.5, p=0.263). At E9.5 (A), there were no differences in heart rates between caffeine and vehicle-treated
groups. At E12.5 (B), caffeine elevated heart rates above vehicle levels. Following addition of caffeine, heart rates in E12.5 specimens did not vary over
time, suggesting the caffeine effects did not significantly diminish in the time required for experiments (p=0.093). C and D: The effects of hypoxia
were determined at both ages in the presence of 200 mM caffeine (E9.5, n=20; E12.5, n=22) or vehicle (E9.5, n=19; E12.5, n=22). At both ages, heart
rates decreased in hypoxia (gray boxes) and increased following recovery in room air (C and D, vehicle, p,0.0001). At E9.5 (C), caffeine treatment
completely inhibited hypoxia-mediated decrease in heart rates (p=0.038). At E12.5 (D), caffeine treatment elevated heart rates and blunted hypoxia-
mediated decrease in heart rate (p=0.002). Heart rates were normalized to baseline. Mean 6 SEM are shown. * p,0.05, ** p,0.001, caffeine
compared to vehicle at each time point.
doi:10.1371/journal.pone.0028296.g003
Figure 4. Expression of adenosine receptor subtypes in E9.5 and E12.5 hearts. Real-time PCR analysis was performed on RNA samples
extracted from isolated hearts at (A) E9.5 and (B) E12.5. Adenosine receptor gene expression was compared to Rp113a expression to determine the
mean normalized expression. Each analysis was performed in triplicate.
doi:10.1371/journal.pone.0028296.g004
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A1AR 2/2 hearts slightly decreased initially and then increase
9% above baseline levels 20 min after hypoxia exposure
(t=40 min) before returning to baseline following recovery in
room air (Fig. 7A). This response profile for the E9.5 A1AR 2/2
hearts may be caused by the fact that E9.5 hearts are not as
sensitive to hypoxia compared to older E12.5 hearts, and therefore
it takes longer to observe the effects of A1AR loss on heart rates.
At E12.5, heart rates decreased in hypoxia independent of
genotype (Fig. 7B). In hypoxia, heart rates of A1AR +/+ hearts
had a maximal decrease of 20% (data not shown), those of A1AR
+/2 hearts decreased by 17%, and those of A1AR 2/2 hearts
decreased by 13% (Fig. 7B). When heart rates were analyzed as a
percent of baseline levels, there were no statistically significant
differences in responses to hypoxia among the different genotypes
(Fig. 7B), indicating that hypoxia resulted in proportional
decreases in heart rate.
Because A1AR2/2 baseline heart rates are higher than
A1AR+/+ and A1AR+/2 littermates, we compared heart rates
that were not normalized to baseline rates (Fig. 7C). Hypoxia
Figure 5. Effects of adenosine receptor-specific antagonists on
responses to hypoxia at E9.5 and E12.5. A and B: Specimens were
treated with DPCPX, an A1AR-specific antagonist at 10 nM (A: E9.5,
n=15; B: E12.5, n=23), SCH-58261, an A2aAR-specific antagonist at
100 nM (A: E9.5, n=15; B: E12.5, n=19), or vehicle (A: E9.5, n=27; B:
E12.5, n=42) at 15 min (arrows), and exposed to hypoxia (gray boxes).
At both ages, heart rates were not affected by SCH-58261 treatment (A
and B). In contrast, at both ages DPCPX elevated heart rates above
vehicle levels in normoxic conditions and inhibited hypoxia-mediated
heart rate decrease below baseline (A and B). Although E12.5 heart rates
did not fall below baseline in hypoxia, heart rates decreased compared
to levels following DPCPX addition in room air (p,0.01 and p,0.0001,
for t=50 min and t=65 min compared to t=20 min, respectively, B). C:
Because heart rates in E12.5 DPCPX-treated hearts significantly
decreased in hypoxia, responses to DPCPX were examined over time
in normoxia. E12.5 hearts were treated with 10 nM DPCPX (n=19) or
vehicle (n=19). DPCPX- mediated heart rate elevation did not
significantly diminish over time compared to levels at t=20 min. Heart
rates were normalized to baseline. Mean 6 SEM are shown. * p,0.05,
** p,0.001, DPCPX compared to vehicle at each time point; { p,0.05
compared to DPCPX at t=20 min.
doi:10.1371/journal.pone.0028296.g005
Table 1. Mean baseline heart rates in A1AR transgenic
embryos.
Genotype BHR (in BPM) CI (95%) p n
E9.5 A1AR +/+ 122.9 115.7–130.2 0.71 25
A1AR +/2 126.7 121.3–132.1 50
A1AR 2/2 125.9 115.1–136.7 15
E12.5 A1AR +/+ 146.7 129.5–164.2 0.01 20
A1AR +/2 150.3 139.5–161 45
A1AR 2/2 171.9 * { 162.2–181.6 31
Statistical analyses performed were repeated-measures one-way ANOVA
followed by Bonferroni post hoc test.
*p,0.05, compared to A1AR +/+;
{p,0.05, compared to A1AR +/2. BHR, baseline heart rate; BPM, beats per
minute; CI, confidence interval.
doi:10.1371/journal.pone.0028296.t001
Figure 6. Effects of A1AR expression on response to caffeine at
E12.5. Isolated hearts lacking A1ARs (2/2) were treated with 200 mM
caffeine (n=16) or vehicle (n=10). Hearts from A1AR +/2 littermates
were treated with 200 mM caffeine (n=18) or vehicle (n=20). Caffeine
treatment elevated heart rates in cultured hearts expressing A1ARs
(p=0.03). In hearts lacking A1ARs, caffeine treatment had no significant
effect on heart rate (p=0.101). Heart rates were normalized to baseline.
Mean 6 SEM are shown. * p=0.03 caffeine compared to vehicle,
unpaired Student’s t-test.
doi:10.1371/journal.pone.0028296.g006
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hearts, but A1AR 2/2 heart rates never fell below the baseline
heart rate of A1AR+/+ hearts in room air (Fig. 7C). These data
indicate that at E9.5 hypoxia-induced bradycardia is mediated by
A1AR signaling, whereas at E12.5 hypoxia also induces bradycar-
dia through non-A1AR pathways (Fig. 8).
Discussion
Evidence shows that adenosine acts via A1ARs to protect
embryos from hypoxia [9,20]; however the mechanisms by which
A1ARs confer embryo protection remain poorly understood
[9,20]. To address this issue, we investigated whether A1AR
signaling modulates embryonic cardiac function, in responses to
hypoxia. We now show that hypoxia decreases embryonic heart
rate through A1ARs in early embryonic hearts (E9.5) and that
this normal physiological response is blocked by caffeine via
blockade of adenosine action on A1ARs. In addition, we
demonstrate that inhibition of A1AR signaling, either by drug
treatment or gene knockout, in older hearts (E12.5) leads to
elevated heart rates. In contrast to E9.5, E12.5 hearts have
reduced heart rates in response to hypoxia evenin thepresenceof
A1AR antagonists. This indicates that older hearts have other
non-A1AR pathways that can mediate hypoxia induced brady-
cardia (Fig. 8).
Previous studies examining murine embryos in situ via
hysterectomy demonstrated that hypoxia reduces heart rates
and that this effect is greater in older embryos [37,38]. Our
studies similarly showed that E12.5 embryonic hearts had a
greater reduction in heart rate in response to hypoxia as
compared to E9.5 hearts. These results show that intrinsic
embryonic and/or cardiac factors contribute to hypoxia-mediat-
ed bradycardia during embryogenesis rather than maternal or
placental effects.
The developing cardiovascular system is vulnerable to hemo-
dynamic stress [6,39–42] and abnormal nutritional support
[43–45]. Therefore, altered embryonic heart rate will have direct
consequences on the developing embryo and fetus [46–48].
In adult and embryonic mice, A1AR activation has been shown
to potently reduce heart rates [19,49]. We observed that the
A1AR-specific antagonist DPCPX completely abolished hypoxia-
mediated heart rate reductions at E9.5 and prevented heart rate
reductions in E12.5 hearts from going below baseline heart rates.
In comparison, no effects of A2aAR antagonism were seen. These
observations highlight the dominant role for A1ARs in mediating
adenosine action in embryos. Further supporting this notion, at
E9.5, embryos lacking A1ARs had impaired responses to hypoxia
characterized by an increase in heart rate after 20 min compared
to a decrease in heart rate observed in A1AR+/2 littermates. At
E12.5, A1AR 2/2 heart rates failed to decrease to levels
comparable to those of littermates expressing A1ARs when
exposed to hypoxia. Although A1AR2/2 hearts reduced their
heart rate in response to hypoxia, there may still be a negative
effect on heart development if the decrease is not enough to trigger
a protective response to hypoxia.
Significant heart rate elevations were observed at caffeine
concentrations as low as 100 mM, which is comparable to caffeine
levels produced with common human caffeine ingestion [22]. At
higher doses of caffeine of 1 mM, we saw diminished chronotropic
effects. It is possible that the effects of caffeine observed at 1 mM
reflect non-adenosine antagonism mechanisms. Positive chrono-
tropic effects of caffeine have been observed in human embryonic
and fetal hearts in culture [50–53]. Yet, studies examining the in
vivo hemodynamic effects of caffeine in human pregnancy have
been inconsistent, and have shown that caffeine decreases or has
no effect on fetal heart rate [54–57]. In addition, it has been
demonstrated that adult mice heterozygous for both A1 and A2a
Figure 7. Effects of A1AR expression on response to hypoxia at
E9.5 and E12.5. A: At E9.5, responses to hypoxia in A1AR 2/2
(n=15) and A1AR +/2 (n=50) embryos were studied. In hypoxia, E9.5
A1AR +/2 heart rates decreased then returned to baseline levels
following recovery in room air (p,0.0001 and p,0.01, for t=25 and
t=40 compared to t=0, respectively). E9.5 A1AR 2/2 responses to
hypoxia were impaired as compared to controls, where responses
were characterized by initial heart rate reductions followed by
paradoxical heart rate elevations above A1AR +/2 levels. B: At E12.5,
hypoxia decreased heart rates below baseline in both hearts lacking
A1ARs (n=31) and those of control A1AR +/2 littermates (n=45;
p,0.0001). When heart rates were analyzed as a percent of baseline
levels there was no statistically significant difference in overall
response among the different genotypes (p=0.612). Because lack of
A1ARs resulted in increased baseline heart rates when compared to
those of control (p,0.05), non-normalized was also analyzed (C). This
observation revealed that although hypoxia caused proportional
decreases in heart rate independent of A1ARs, without A1ARs heart
rates remained elevated above controls (p=0.004). Mean 6 SEM are
shown. * p,0.01, ** p,0.0001, A1AR2/2 compared to A1AR+/2 at
each me point.
doi:10.1371/journal.pone.0028296.g007
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effects include decreased heart rate [58]. In mice, daily caffeine
doses of 10 mg/kg were associated with embryonic size reduction
that were thought to be mediated through A2aARs, but no
changes in heart rates were observed [59]. That study, though, was
performed under isofluorane sedation [59], and may have masked
effects of caffeine on heart rates. Considering the challenges
associated with in vivo models, our embryonic tissue cultures
allowed direct examination of effects of caffeine and hypoxia on
embryonic heart rate, revealing direct effects on embryos and
hearts.
It is important to note that although our focus is on A1ARs and
a prominent A1AR effect was observed, other adenosine receptor
subtypes may play a role in mediating effects of hypoxia. A2bARs
and other signaling pathways that are implicated in hypoxia
responses have been observed, with hypoxia inducing A2bAR
expression along with enzymes that increase adenosine production
[60].
In humans, effects of caffeine on the embryonic [54,55,57],
uteroplacental [55,56], and maternal [54–57,61,62] circulations
have been observed. These results have indicated that caffeine
increases uteroplacental and fetal vascular resistance, possibly
through both direct antagonism of vascular adenosine receptors
and increased release of catecholamines [55–57]. With the
exception of one study [57], most of these reports examined
effects of caffeine on second or third trimester pregnancies. In
comparison, our study was performed at stages that are equivalent
to the first trimester in humans.
We believe that our studies are clinically relevant for several
reasons. First, we observed that baseline heart rates were very
similar to those obtained in vivo in murine embryos [4,33–35].
Second, although heart rate is dependent on stroke volume and
thus preload, afterload, and contractility via neural feedback loops
in mature mammals, the sympathetic and parasympathetic
neurons first innervate the heart much later in gestation than
the ages we studied [63,64]. Third, we are unaware of other
systems in which individual murine embryos can be treated with
specific concentrations of drugs for a prolonged period indepen-
dent of maternal or placental physiologic effects.
In summary, we demonstrated that hypoxia decreases heart
rates in E9.5 and E12.5 embryos, and that caffeine disrupts this
response by elevating embryonic heart rates through inhibition of
A1AR action. These results raise concern for caffeine exposure
during embryogenesis, especially in pregnancies with increased
risk of embryonic hypoxia, including placental insufficiency,
anemia, maternal smoking and living in high altitudes [7]. Our
observations are consistent with other reports suggesting that
adverse effects of caffeine ingestion are strongest during early
pregnancy [30]. Additional studies on the effects of caffeine
exposure on developing embryos and embryonic heart function
are needed.
Materials and Methods
Animals
The Institutional Animal Care and Use Committee (IACUC) of
Yale University approved all experiments conducted on animals
(protocol #2007-11136). The inbred mouse strain C57Bl/6
(Charles River Laboratories, Wilmington, MA) and A1AR-
deficient mice (A1AR 2/2) were studied [65]. Timed matings
were used to obtain the appropriate age embryos, with E0.5
designating the day a vaginal plug was observed. To genotype
A1AR transgenic mice, genomic DNA extraction and PCR were
performed as described [66].
Tissue Cultures
Embryos and hearts were cultured as described [19]. Hyster-
ectomy was performed under sterile conditions, and uteri were
rinsed in Dulbecco’s PBS (DPBS) with 2 mM MgCl2. Embryonic
age was determined by morphology and somite number [67]. E9.5
embryos were cultured intact with yolk sacs removed and
pericardia punctured. At E12.5, isolated hearts were studied.
Embryonic tissues were transferred into individual wells contain-
ing DMEM with 10% fetal bovine serum (Fetal Clone II, Hyclone
Laboratories, Logan, UT) and 50 mM HEPES, pH 7.3, buffer.
Specimens were incubated at 37uC in a 5% CO2 –room air
incubator for 1–2 h prior to conducting tissue hypoxia studies and
heart rate analyses.
Tissue Hypoxia Assessment
To assess if there was embryonic tissue hypoxia associated with
2% O2 exposure, C57Bl/6 embryonic tissues were cultured with
200 mM Hypoxyprobe-1 (pimonidazole; Chemicon International,
Temecula, CA). Hypoxyprobe-1 forms protein adducts in O2
levels ,10 mm Hg that can be detected by immunostaining [11].
Following a 1 h incubation period, embryos or hearts were
exposed to 2% O2 in a Plexiglass chamber (Biospherix, Redfield,
Figure 8. Schematic of influences of adenosine and hypoxia on embryonic heart rate regulation. Hypoxia induces increased levels of
adenosine, which in turn activate A1ARs to lower heart rate. Reduction in heart rate will affect embryonic tissue perfusion, which in turn will influence
embryonic development. At E9.5, effects of hypoxia on heart rate appear to be exclusively mediated via A1ARs. At E12.5, hypoxia also can influence
heart rate independent of A1ARs. Caffeine, an adenosine antagonist, will perturb this physiological cascade.
doi:10.1371/journal.pone.0028296.g008
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O2 levels were maintained at 2% with a regulator (Biospherix) by
introducing 95% nitrogen with 5% CO2 into the chamber.
Chamber temperature was maintained between 35uCa n d3 7 uC
with a heating cord. Tissues were fixed in 4% paraformaldehyde,
embedded in paraffin, and sectioned. Conjugates were visualized
with a monoclonal antibody to Hypoxyprobe-1 (Chemicon
International, Temecula, CA) followed by a goat anti-mouse
secondary antibody conjugated to Alexa488 (Santa Cruz
Biotechnology, Santa Cruz, CA), as described [9]. Images were
captured with an Olympus Fluoview laser scanning confocal
microscope.
Heart Rate Studies
Heart rate assessment. Using the chamber described
above, heart rate measurements were performed through direct
visualization with a dissecting microscope over 15-second intervals
by a single individual who was blinded to treatment conditions.
Measurements were performed in triplicate per sample at each
time point.
Caffeine Concentration-Response Studies. To generate
concentration-response curves at E9.5 and E12.5 under
normoxic conditions, individual specimens of the C57Bl/6
strain were treated with vehicle or increasing concentrations of
caffeine (Sigma-Aldrich, St. Lou i s ,M O ) .S i xt o1 2s p e c i m e n s
were analyzed per experiment. Following a 1–2 h initial
incubation period, the baseline heart rate for each specimen
was measured. Individual specimens were treated with increasing
concentrations of caffeine (1 mM, 10 mM, 100 mM, and 1 mM) or
vehicle without changing the media, and heart rates were
reassessed after 2 min. In addition, at E12.5, individual hearts
were treated with vehicle or a single concentration of caffeine
(50 mM, 100 mM, 200 mM, 400 mM, or 1 mM) to refine the
concentration-response curves.
Effects of Hypoxia and Adenosine Receptor Antagonists
on Heart Rate. Heart rates of C57Bl/6 embryos were assessed
following hypoxia exposure and/or treatment with adenosine
receptor antagonists. Cultures were treated with 200 mMc a f f e i n e .
Thisconcentrationwasselectedbasedonourcaffeineconcentration-
response data (see Results). In addition, some cultures were treated
with 10 nM 1,3-dipropyl-8-cyclopentylxanthine (DPCPX; Sigma-
Aldrich, St. Louis, MO), an A1AR-specific antagonist, and 100 nM
SCH-58261 (Sigma-Aldrich, St. Louis, MO), an A2aAR-specific
antagonist. The concentrations were chosen based on previous
reports [68].
Heart rate experiments began after an initial 1–2 h incubation
period following dissections. Plates containing 6–12 specimens
were placed in the chamber and baseline heart rates were
measured (time [t]=0 min). Drugs or vehicle were added to each
well in a blinded fashion and heart rates were reassessed after
5 min (t=20 min). The chamber oxygen levels were lowered to
2.0%. This O2 level was selected based on our Hypoxyprobe-1
studies that showed increased tissue hypoxia while embryonic
cardiac function was preserved. Heart rates were measured after
5 min in 2.0% O2 (t=50 min) and 20 min in 2.0% O2
(t=65 min). Finally, heart rates were reassessed after a 10 min
recovery period in room air O2 (t=100 min). In control
experiments to show that embryonic heart function in culture is
stable over time, heart rates were assessed at these time points
without hypoxia or caffeine treatment.
Heart rate analysis of A1AR knockout mice. Effects of
caffeine and hypoxia on A1AR knockout mice was determined as
described above for C57Bl/6 mice.
Real-Time RT-PCR Analysis for Adenosine Receptors
Gene expression was determined for all four adenosine
receptor subtypes in isolated hearts from E9.5 and E12.5
C57Bl/6 embryos, as described [69]. Isolated hearts were
collected. Tissue was rinsed in DPBS, placed in 1.5 ml
microcentrifuge tubes, flash frozen in liquid nitrogen, and stored
at 280uC until RNA isolation. Total RNA was extracted
according to the manufacturer’s instructions with the RNeasy
Plus Kit (Qiagen, Valencia, CA), as described [69]. RNA was
isolated from three separate pools of at least 15 hearts each. 1 mg
of RNA was reverse transcribed using the iScript cDNA
Synthesis Kit (Bio-Rad Laboratories, Hercules, CA), as reported
[69]. Each real-time PCR reaction contained IQ SYBR Green
Super Mix (Bio-Rad, Hercules, CA), 50 ng cDNA, and 0.5 mM
of each primer in a 20 ml reaction volume. PCR was performed at
55uC for annealing in an Opticon 2 DNA Engine PCR machine
(Bio-Rad). All primers were designed against mouse sequence
(Rp113a housekeeping gene: forward 59- ATGACAAGAAA-
AAGCGGATG – 39,r e v e r s e5 9 – CTTTTCTGCCTGTTT-
CCGTA – 39;A 1 A R :f o r w a r d5 9 – GTCCTGGTATGTGACC-
AAGC – 39,r e v e r s e5 9 – CTGAGGCTCTGGGTGAACTA 39;
A2aAR: forward 59 – GCAGAACGTCACCAACTTCT – 39,
reverse 59 – ATGGCGATGTATCTGTCGAT – 39; A2bAR:
forward 59 TGCATGCCATCAACTGTATC – 39,r e v e r s e5 9 –
TGGAAACTGTAGCGGAAGTC; A3AR: forward 59 –A G C -
GAGCTCTCAAAATAGCA 39,r e v e r s e5 9 – ATAAAATG-
CACGCGTCTCTC 39) and were obtained from RealTimePri-
mers.com (Elkins Park, PA). Each real-time PCR experiment was
performed in triplicate. PCRs were analyzed by mean normal-
ized expression using Microsoft Excel, with Rp113a as the
control gene. DNA contamination was assessed by a ‘‘no RT
control’’ real-time PCR reaction, no DNA contamination was
observed.
Statistical Analysis
Heart rates were measured in triplicate and recorded in a
spreadsheet (Microsoft Excel) where average heart rate in beats-
per-minute (BPM) were calculated. To standardize heart rates
from all studies, heart rates were recorded as percent change from
baseline using the formula: percent change=heart Rate/base-
line6100. Descriptive statistics including 95% confidence intervals
(CI) were calculated using Excel (Microsoft, Redmond, WA).
Concentration-response curves were generated using GraphPad
Prism version 5 (GraphPad Software Inc., San Diego, CA). The
EC50, defined as the drug concentration that caused heart rates to
increase to levels halfway between baseline and maximum levels,
was obtained from these curves where the lowest concentration
corresponded to the addition of vehicle. The maximal mean
increase in heart rate from basal levels was defined as Emax.
Differences in response profiles over time between treatment or
genotype groups were analyzed with repeated measures two-way
ANOVA, differences within groups at different time points were
analyzed with repeated measures one-way ANOVA, and differ-
ences in mean baseline heart rates were analyzed with unpaired
Student’s t-test assuming equal variances or one-way ANOVA.
Bonferroni’s tests were used for post hoc analyses. Data are
presented as mean +/2 the standard error of the mean (SEM).
Two-tailed p,0.05 was considered to be statistically significant.
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